With this issue, the Journal of Pharmacological and Experimental Therapeutics (JPET) has added a new subject category entitled “Drug Discovery and Translational Medicine.” JPET has a well established history of publishing articles that describe the discovery and development of novel chemical entities. With the formal establishment of this new section, the Editorial Board is furthering its efforts to provide authors and the JPET readership with a forum for the communication of state-of-the-art research in this important and evolving field of pharmacological research and its translation to effective therapies. Manuscripts that address issues involved in preclinical and clinical drug discovery and development are within the scope of this new section, as are those that demonstrate novel translational strategies for validating pharmacological mechanisms in early clinical studies. Many members of the Editorial Board have extensive expertise in these areas, and we are committed to offering our authors an enhanced level of consistent and timely feedback on manuscripts covering these topics.
In addition, in this issue of JPET is the first “miniseries” of Perspectives in Pharmacology (PiP). This collection of PiPs on Histamine H3 Receptors was generated by leading academic and industrial investigators in this field and offers the readership an authoritative overview of the latest advances in delineating the role of H3 receptors in the modulation of central nervous system physiology. A future miniseries of PiPs will focus on the use of translational imaging in the areas of cancer, cardiovascular, pulmonary, and drug abuse research. Additional PiPs will appear in future issues on the functional selectivity of ligands and the role of histone deacetylases in different diseases. The JPET Editorial Board invites authors to submit proposals for individual or miniseries PiPs on any pharmacological topic that will have broad interest to the JPET readership. Proposals for new PiPs can be sent to.
Finally, the ASPET Board of Publication Trustees recently implemented new requirements for establishing and disclosing authorship contribution information for articles published in ASPET journals. These requirements and procedures can be found in the “Instructions to Authors.” The specific roles of all authors and coauthors will now be indicated in a designated section that will appear before the reference section for all articles published in JPET. These requirements are consistent with the best practices of the leading journals in biomedical science and will help ensure a greater level of authorship transparency and accountability for the research communicated in JPET articles.
I hope the readers of JPET will find these changes of value. Please feel free to contact me () or Jill Filler ( ), the Managing Editor, if you have any comments or suggestions regarding the journal.
- Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics